New Blood Test Offers Hope for Early Detection of Pancreatic Cancer

Researchers have made significant strides in the fight against pancreatic cancer, a disease known for its late diagnosis and high mortality rate. The Grail Galleri blood test is emerging as a promising tool that can screen for over 50 types of cancer, including pancreatic cancer. This test is especially notable because it offers a potential screening option for a disease that currently lacks a standard early detection method.

According to experts, the early stages of pancreatic cancer are often asymptomatic, which complicates timely diagnosis. In Ohio alone, an average of 2,168 cases of pancreatic cancer were diagnosed annually between 2017 and 2021, making it the third leading cause of cancer-related deaths in the state. Tragically, the disease led to an average of 1,899 deaths each year during that same period, as reported by the Ohio Department of Health.

Detection Challenges and New Hope

The Grail Galleri blood test screens individuals over the age of 50 and detects cancer in approximately 1 in 200 cases among asymptomatic patients. This detection rate improves significantly to 1 in 20 for those presenting new symptoms. Dr. Jordan Winter, a pancreatic cancer specialist at University Hospitals Seidman Cancer Center, emphasizes the importance of early detection, stating, “If you detect it early enough, then the cure rate can be as high as 20%.”

Despite these promising figures, pancreatic cancer remains a formidable opponent. A report from the American Cancer Society estimates that 67,440 patients will be diagnosed with pancreatic cancer in 2025, with nearly 52,000 fatalities expected. These statistics highlight a persistent challenge, as only 11 percent of patients survive five years post-diagnosis, consistent with the national average.

Dr. Winter notes that many cases are diagnosed at advanced stages when surgical options are limited, with 60 to 70 percent identified too late for curative treatment. “We can correlate that to both the lack of an early detection test as well as poor treatment options,” he adds.

Understanding the Disease

The pancreas, a vital organ located between the stomach and spine, plays a crucial role in digestion and blood sugar regulation. Early detection of pancreatic cancer significantly improves treatment outcomes, yet many patients present with vague symptoms such as abdominal pain, weight loss, and new-onset diabetes. Other indicators can include jaundice, itchy skin, and changes in stool color. Dr. Winter remarks, “Pancreas cancer often presents with very non-specific symptoms that typically are caused by other underlying processes.”

Age is a major risk factor, with the disease primarily affecting individuals in their 60s and 70s, although it can occur in younger adults as well. Lifestyle factors such as smoking, obesity, and chronic pancreatitis increase the likelihood of developing the disease. Notably, having a family history of pancreatic cancer can triple the risk, while having two close relatives can increase it sixfold. Furthermore, data indicate that Black individuals face the highest incidence and mortality rates from this cancer.

In Ohio, Cuyahoga County reported the highest rates of pancreatic cancer from 2017 to 2021, averaging 255 cases and 235 deaths annually. Franklin County followed with an average of 188 cases and 158 deaths per year. These figures underscore the urgent need for early detection solutions.

Dr. Winter, who leads the Winter Lab at Case Comprehensive Cancer Center, is dedicated to exploring effective therapies for pancreatic cancer. Ongoing clinical trials are investigating innovative treatments, including KRAS inhibitors and vaccines aimed at preventing cancer recurrence post-surgery. He encourages patients to consider participating in these trials, stating, “Consideration for clinical trials is so important because those trials may help their loved one, but they also help us learn more about how to treat this disease better.”

As the medical community works to improve outcomes for pancreatic cancer, public involvement remains crucial. Events like PurpleStride, scheduled for April, aim to raise awareness and funds for research. “There’s a lot of hope for people who have it detected early enough and are getting surgery for pancreatic cancer,” Dr. Winter concludes.